IndraLab

Statements


Mutated OTULIN activates anti-TNF neutralizing antibody. 1 / 1
| 1

reach
"Here, we describe that a homozygous hypomorphic OTULIN mutation in a consanguineous family causes a potentially fatal autoinflammatory disorder termed OTULIN related autoinflammatory syndrome (ORAS), which can be managed by Infliximab (anti-TNF neutralizing antibody)."